4//SEC Filing
Klinger Shannon Thyme 4
Accession 0001127602-25-021028
CIK 0001682852other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:10 PM ET
Size
13.8 KB
Accession
0001127602-25-021028
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Klinger Shannon Thyme
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-27+774→ 28,257 total - Exercise/Conversion
Common Stock
2025-08-28+329→ 28,211 total - Tax Payment
Common Stock
2025-08-28$25.10/sh−160$4,016→ 28,051 total - Exercise/Conversion
Restricted Stock Units
2025-08-28−329→ 1,973 total→ Common Stock (329 underlying) - Exercise/Conversion
Restricted Stock Units
2025-08-27−774→ 7,736 total→ Common Stock (774 underlying) - Tax Payment
Common Stock
2025-08-27$24.73/sh−375$9,274→ 27,882 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- [F3]25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F4]25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001866132
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:10 PM ET
- Size
- 13.8 KB